PRQR logo

ProQR Therapeutics NV (PRQR) Short Term Debt

PRQR Annual Short Term Debt

$1.78 M
-$2.38 M-57.20%

31 December 2023

PRQR Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRQR Quarterly Short Term Debt

$6.59 M
+$33.70 K+0.51%

01 September 2024

PRQR Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRQR Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-57.2%+62.7%
3 y3 years-39.4%+105.6%
5 y5 years+100.0%+105.6%

PRQR Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-75.0%at low-26.6%+269.1%
5 y5-year-75.0%+87.2%-26.6%+734.1%
alltimeall time-75.0%-26.6%

ProQR Therapeutics NV Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$6.59 M(+0.5%)
June 2024
-
$6.55 M(+3.7%)
Mar 2024
-
$6.32 M(+254.3%)
Dec 2023
$1.78 M(-57.2%)
$1.78 M(-55.9%)
Sept 2023
-
$4.05 M(-12.4%)
June 2023
-
$4.62 M(+3.8%)
Mar 2023
-
$4.46 M(+6.9%)
Dec 2022
$4.17 M(-41.6%)
$4.17 M(+30.2%)
Sept 2022
-
$3.20 M(-64.3%)
June 2022
-
$8.98 M(+4.2%)
Mar 2022
-
$8.61 M(+20.7%)
Dec 2021
$7.14 M(+142.3%)
$7.14 M(+93.2%)
Sept 2021
-
$3.70 M(+5.4%)
June 2021
-
$3.50 M(+26.8%)
Mar 2021
-
$2.76 M(-6.2%)
Dec 2020
$2.95 M(+209.0%)
$2.95 M(+11.2%)
Sept 2020
-
$2.65 M(+235.6%)
June 2020
-
$789.50 K(-13.2%)
Mar 2020
-
$909.90 K(-4.6%)
Dec 2019
$953.30 K
$953.30 K(-24.2%)
DateAnnualQuarterly
Sept 2019
-
$1.26 M(-18.5%)
June 2019
-
$1.54 M(+8.9%)
Mar 2019
-
$1.42 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2018
-
$2.32 M(+0.5%)
June 2018
-
$2.31 M(-6.2%)
Mar 2018
-
$2.47 M(+4.9%)
Dec 2017
$2.35 M(>+9900.0%)
$2.35 M(+18.5%)
Sept 2016
-
$1.98 M(>+9900.0%)
June 2016
-
$0.00(-100.0%)
Mar 2016
-
$7900.00(-51.8%)
Dec 2015
$16.40 K(-60.3%)
$16.40 K(-33.9%)
Sept 2015
-
$24.80 K(-23.7%)
June 2015
-
$32.50 K(0.0%)
Mar 2015
-
$32.50 K(-21.3%)
Dec 2014
$41.30 K(-98.8%)
$41.30 K(+117.4%)
Sept 2014
-
$19.00 K(-59.1%)
June 2014
-
$46.40 K(-98.7%)
Dec 2013
$3.52 M(>+9900.0%)
$3.52 M
Dec 2012
$0.00
-

FAQ

  • What is ProQR Therapeutics NV annual short term debt?
  • What is the all time high annual short term debt for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual short term debt year-on-year change?
  • What is ProQR Therapeutics NV quarterly short term debt?
  • What is the all time high quarterly short term debt for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly short term debt year-on-year change?

What is ProQR Therapeutics NV annual short term debt?

The current annual short term debt of PRQR is $1.78 M

What is the all time high annual short term debt for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual short term debt is $7.14 M

What is ProQR Therapeutics NV annual short term debt year-on-year change?

Over the past year, PRQR annual short term debt has changed by -$2.38 M (-57.20%)

What is ProQR Therapeutics NV quarterly short term debt?

The current quarterly short term debt of PRQR is $6.59 M

What is the all time high quarterly short term debt for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly short term debt is $8.98 M

What is ProQR Therapeutics NV quarterly short term debt year-on-year change?

Over the past year, PRQR quarterly short term debt has changed by +$2.54 M (+62.69%)